Cookies show us what works. Privacy
Cookies show us what works. Privacy
HCA Healthcare (HCA) has not announced its next earnings date. The next report covers the quarter ending Dec 31, 2026. A year earlier it reported the same quarter on Jan 27, 2026. Analysts expect earnings per share of $8.21 (20 analysts) on revenue of $20.0B.
Last report, Oct 27, 2026: EPS $7.22 against $6.74 expected (+7.1%). The stock moved +3.0% the next day. Beat the EPS estimate in 8 of the last 8 reports. The stock moved 3.1% on average the next day, up or down; the largest move was +6.0%.
| Reported | Quarter ended | EPS | Estimate | Surprise | Next day |
|---|---|---|---|---|---|
| Oct 27, 2026 | Sep 30, 2026 | $7.22 | $6.74 | +7.1% | +3.0% |
| Jul 24, 2026 | Jun 30, 2026 | $7.59 | $7.57 | +0.3% | +1.9% |
| Apr 24, 2026 | Mar 31, 2026 | $7.15 | $7.13 | +0.3% | +3.1% |
| Jan 27, 2026 | Dec 31, 2025 | $8.01 | $7.48 | +7.1% | -2.9% |
| Oct 24, 2025 | Sep 30, 2025 | $6.96 | $5.73 | +21.5% | +4.7% |
| Jul 25, 2025 | Jun 30, 2025 | $6.84 | $6.32 | +8.2% | +1.9% |
| Apr 25, 2025 | Mar 31, 2025 | $6.45 | $5.75 | +12.2% | +1.3% |
| Jan 24, 2025 | Dec 31, 2024 | $6.22 | $6.14 | +1.3% | +6.0% |
HCA Healthcare (HCA) has not announced its next earnings date. The next report covers the quarter ending Dec 31, 2026. A year earlier it reported the same quarter on Jan 27, 2026.
$8.21 a share, the average of 20 analysts, for the quarter ending Dec 31, 2026. The revenue estimate is $20.0B.
Yes. Last report, Oct 27, 2026: EPS $7.22 against $6.74 expected (+7.1%). The stock moved +3.0% the next day.
Report dates come from the Alpha Vantage earnings calendar and stay expected until the company confirms them. EPS is as reported against the analyst average; the next-day move is close to close. Not investment advice.